Hipertiroidismo como manifestación de la enfermedad trofoblástica gestacional: a propósito de un caso

Gestational trophoblastic disease (GTD) is a group of tumours caused by the hyperproliferation of trophoblast cells and is noted for its overproduction of hCG. Among its manifestations, there may be hyperthyroidism, due to the stimulating activity of hCG on TSH receptors. In most cases it is only a biochemical hyperthyroidism, with its presentation as symptomatic hyperthyroidism being much less frequent. We report the case of a patient with GTD, who at diagnosis presented with symptomatic hyperthyroidism. Treatment included surgical evacuation of the hydatidiform mole, as well as a beta-blocker and antithyroid drug treatment to relieve the symptoms.     

滋阴清热方治疗对甲状腺功能亢进症阴虚火旺证患者疗效、血浆内皮素-1、炎症因子和免疫功能的影响

目的:研究滋阴清热方治疗对甲状腺功能亢进症阴虚火旺证患者疗效、血浆内皮素-1、炎症因子和免疫功能的影响。方法:将广州市花都区妇幼保健院收治的100例甲状腺功能亢进症阴虚火旺证患者分成观察组和对照组。对照组:给患者使用常规药物治疗;观察组:在对照组的基础上,给予滋阴清热方治疗。干预后,比较两组患者的临床疗效、血浆内皮素-1(Endothelin,ET)、炎症因子[白介素-2(Interleukin-2,IL-2)、白介素-8(Interleukin-8,IL-8)]及肿瘤坏死因子(Tumour Necrosis Factor-α,TNF-α)和免疫功能(CD3^+、CD4^+、CD8^+及CD4^+/CD8^+)。结果:干预前,两组患者IL-2、IL-8及TNF-α无变化,差异无统计学意义(P>0.05);干预后,观察组患者的IL-2比对照组高,且对照组的IL-8及TNF-α比观察组的高,P<0.05,差异有统计学意义;干预前,两组患者的CD3^+、CD4^+、CD8^+及CD4^+/CD8^+与ET无变化;干预后,观察组的CD3^+、CD4^+、CD8+及CD4^+/CD8^+比对照组高,P <0.05,差异有统计学意义,且观察组的ET低于对照组且观察组总有效率明显高于对照组。结论:滋阴清热方治疗降低了血浆内皮素-1,减少炎症的出现,提高免疫功能。     

“L”形拉钩在腔镜甲状腺功能亢进手术中的应用研究

目的：研究“L”形拉钩在腔镜甲状腺功能亢进手术中的应用价值。方法整群抽选2013年7月-2014年8月该院收治的甲状腺功能亢进患者112例，随机法分为观察组(n=56﹚和对照组(n=56﹚，观察组行“L”形拉钩腔镜甲状腺大部切除术，对照组采用常规腔镜手术方法切除，术中缝扎腺体进行牵拉。比较两组患者手术时间、术中出血量、住院时间及并发症发生情况。结果观察组手术时间(109.8±12.4﹚min、出血量(106.3±15.7﹚mL、住院时间(5.3±1.2﹚d与对照组(138.6±56.2﹚min、(147.2±50.9﹚mL、(7.6±2.8﹚d比较显著较少，差异有统计学意义(P<0.05﹚；观察组并发症发生率7.1%显著低于对照组26.8%，差异有统计学意义(P<0.05﹚。结论“L”形拉钩应用于腔镜甲状腺功能亢进手术中，操作方便、简单，能显著缩短手术时间、减少出血量，且术后并发症少，安全性高，值得推广。     

Systemic lupus erythematosus and thyroid disease – Experience in a single medical center in Taiwan

BackgroundTo investigate the association of systemic lupus erythematosus (SLE) with thyroid diseases in a medical center in central Taiwan.MethodsThis is a retrospective cohort of 2796 SLE patients in a tertiary referral medical center from 2000 to 2013. We screened SLE by catastrophic illness registration from national insurance bureau; and thyroid diseases by ICD 9 codes, then confirmed by thyroid function test, auto-antibody, medical and/or surgical intervention. We compared the rate of hyperthyroidism, hypothyroidism and autoimmune thyroid disease (AITD) in SLE patients and the 11,184 match controls. We calculated the rate of these thyroid diseases and positive antibodies to thyroglobulin (ATGAb), thyroid peroxidase (TPOAb) in SLE patients grouped by the presence of overlap syndrome and anti-dsDNA antibody. We also compared the association of thyroid diseases to severe SLE conditions, including renal, central nervous system (CNS) involvement, and thrombocytopenia.ResultsCompared to the matched controls, the cumulative incidence of thyroid disease, including hyperthyroidism, hypothyroidism and AITD, were all higher in SLE patients (p < 0.0001). The average age of SLE patients with thyroid diseases patients were older than those without thyroid diseases (p = 0.002). Those had euthyroid AITD were younger than other patients with thyroid diseases (p = 0.02). Up to 30.3% SLE patients had overlap syndrome and had higher relative risk of thyroid diseases than those without overlap syndrome, in terms of hypothyroidism and AITD, but not hyperthyroidism. SLE patients with thyroid diseases also carry higher risk for severe complications such as renal involvement (p = 0.024) central nervous system involvement (p < 0.0001).ConclusionSLE patients had significantly higher rate of hyperthyroidism, hypothyroidism, and AITD than the matched control. Among lupus patients, the risks of thyroid diseases are even higher in the presence of overlap syndrome. SLE patients with thyroid diseases had higher risk of renal and CNS involvement.     

131I治疗对伴巨大甲状腺肿Graves病患者疗效及影响因素分析

目的探讨 131 I治疗对伴巨大甲状腺肿的Graves病患者甲状腺功能和TSH受体抗体(TRAb)的影响,并分析该治疗方法的影响因素。方法选择154例2009年1月至2015年12月在本院住院进行 131I治疗的伴巨大甲状腺肿的Graves病患者(经CT测算甲状腺体积均>100cm^3 ),检测患者治疗前后甲状腺功能及TSH受体抗体的变化,6~24个月随访。疗效按照治疗后甲状腺功能,分为治愈、甲亢部分缓解、甲减以及无效。结果 154例Graves病患者的甲状腺体积为121.08(108.43~143.43)cm^3 。治疗后甲状腺功能恢复正常91例(59.09%),甲亢部分缓解仍需服抗甲状腺药物56例( 36.36%),甲减7例(4.55%)。末次治疗6个月后FT3 、FT4 和TRAb均明显下降,其中,FT3 由治疗前的23.88( 11.49~ 45.81 )pmol/L降低为6.27(4.58~10.07)pmol/L,FT 4 由治疗前的42.08(19.99~100.00)pmol/L下降到19.31( 13.67~ 30.08 )pmol/L,TRAb由35.07(22.82~40.00)IU/L降至21.75(9.46~39.30)IU/L,( P 均<0.05),并且TSH水平上升明显,由治疗前的0.09(0.06~ 0.21 )mIU/L增至0.22(0.09~1.33)mIU/L( P <0.05)。甲功正常组治疗前甲状腺体积为 116.08 (106.95~130.04)cm^3 ,小于部分缓解组125.87(111.86~154.93)cm^3 ( P <0.05)和甲减组145.20( 128.55~ 169.31 )cm^3 ( P <0.05)。 131I治疗巨大甲状腺肿的Graves病患者的转归与患者治疗前的甲状腺体积有关(相关系数 OR = 0.21 , P < 0.05 )。结论 131I治疗可用于巨大甲状腺肿Graves病患者,治疗安全有效,治疗效果与治疗前甲状腺体积有关。     

焦虑抑郁对甲状腺功能亢进患者的影响

  目的   研究焦虑抑郁在甲状腺功能亢进患者中产生的临床影响。  方法  选取2018年9月—2019年2月乐清市人民医院收治的合并及未合并焦虑抑郁甲状腺功能亢进患者各60例,分别设为观察组、对照组,收集2组患者一般资料及临床资料,分析组间数据差异。  结果  观察组甲状腺肿大程度、心率、眼征、TGA阳性、TMA阳性数据与对照组比较差异有统计学意义(χ2=19.394、25.679、14.803、7.350、25.145,均P＜0.05);观察组TT3、TT4、FT3、FT4、TG-Ab、TPOAb与对照组比较差异有统计学意义(t=12.941、11.757、7.756、20.746、8.543、2.637,均P＜0.05);观察组主观支持、客观支持、对支持利用度、社会支持总分均高于对照组(t=3.589、4.194、3.880、4.306,均P＜0.05);观察组躯体化、抑郁、焦虑及恐怖评分均高于对照组(t=4.309、7.582、7.324、11.078,均P＜0.05)。  结论  合并焦虑抑郁的甲状腺功能亢进患者,相对于无焦虑抑郁者,其症状及体征更为明显,社会支持更差,情绪更加不稳定。      

从“肝郁”理论论治甲状腺功能亢进症

"肝郁"是指多种原因引起肝的疏泄功能不及或障碍,以致气机郁滞不畅。临床上甲状腺功能亢进症患者多有急躁易怒、怕热多汗、多食易饥等症状,与"肝郁"具有相似的疾病特征。作者认为"肝郁"是本病的核心病机,治疗上应以"疏肝解郁"为基本治则,辨证论治,随症加减,为甲状腺功能亢进症的治疗提供新思路。     

甲状腺机能亢进患者穴位伏安特性研究

目的:观察甲状腺机能亢进(甲亢)患者与健康人大陵、神门、内关穴伏安特性的变化规律。方法:应用智能型穴位伏安特性检测仪检测56例甲亢患者与40名健康人大陵、神门、内关穴的伏安曲线,并进行比较分析。结果:甲亢患者左大陵穴的惯性面积显著大于健康人(P<0.01),甲亢患者右大陵穴的增、减程伏安面积均显著小于健康人(P<0.01)。甲亢患者左神门穴减程伏安面积和右神门穴的增程伏安面积显著小于健康人(P<0.01)。甲亢患者左内关穴减程伏安面积小于健康人(P<0.05)。结论:甲亢患者穴位的伏安特性较健康人发生变化,且对该疾病的反映主要体现在大陵穴。     

甲状腺疾病、糖尿病相关骨质疏松的病因研究进展

骨质疏松症是临床的常见病和多发病,并严重影响着人们的健康和生活质量,而糖尿病和甲状腺疾病都是继发性骨质疏松的主要病因。了解这两种疾病相关骨质疏松的病因对骨质疏松的治疗和预防有重要意义。本文主要对内分泌代谢病中的甲状腺疾病及糖尿病引起骨质疏松的病因进行了阐述。